BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 29, 2012
View Archived Issues
Tenascin-C evaluated as a marker of isolated noncompaction cardiomyopathy
Read More
DNA decoy to prevent postsurgical pain shows promising preclinical toxicity profile
Read More
Preclinical data support clinical testing of new antiarrhythmic drug
Read More
Theravance product shows strong antinociceptive activity across a range of pain models
Read More
Jakavi approved in Europe
Read More
European Commission approves Zinforo
Read More
Novel agent is active against West Nile virus and other flaviviruses / News in Context
Read More
Bristol-Myers Squibb presents in vivo results on new Trk inhibitors
Read More
New potential cancer therapies developed at U.S. university
Read More
Genmab designs novel CD74-directed immunotherapies
Read More
Novel candidate HIV medicines presented by Bristol-Myers Squibb
Read More
Scientists in U.S. disclose novel HDAC inhibitors
Read More
Boehringer Ingelheim Pharma patents new PI3K-alpha inhibitors
Read More
New MDR efflux pump inhibitors synthesized in France
Read More
Esperance advances phase II trial in ovarian cancer
Read More
New assay to measure testosterone obtains CE mark
Read More
FDA committee to discuss Heplisav BLA
Read More
Biomarker has prognostic value in patients with diabetes and coronary artery disease
Read More
Cangene strengthens biodefense work
Read More
Resverlogix reports topline results from SUSTAIN study
Read More
Health Canada approves Treanda
Read More
Altheus Therapeutics kicks off phase II trial in ulcerative colitis
Read More
Novelos Therapeutics developing optical imaging agent for use in cancer
Read More
First patient enrolled in phase IIa AEZS-130 study
Read More
CE Mark approval for Elixir Medical stent
Read More
Pristine Solutions completes acquisition
Read More
Promising phase IIa data reported on Archexin
Read More